ATATlungchemotherapyimmunotherapybreastdigestive
…).Conclusion and Relevance The proportion of patients receiving AT within 14 days of death (9.5%) was below the 10% threshold desc…
2articles mentioning drugs
7drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: AT ×
AT
This drug is selected. Its supporting articles are shown below.
Articles mentioning AT
2 articles · page 1 of 1osimertinibcrizotinibsotorasibatezolizumabdurvalumablorlatinibosimertinib-treated
…ring may help identify patients who could benefit from extended osimertinib therapy, although further clinical validation is warranted.ctDN…